|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
|
US6964946B1
(en)
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
|
US20030157187A1
(en)
*
|
1996-12-02 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing inflammatory diseases
|
|
US6458373B1
(en)
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US20030087954A1
(en)
*
|
1997-01-07 |
2003-05-08 |
Sonus Pharmaceuticals, Inc. |
Method of treating bladder carcinoma using a Taxane/Tocopherol formulation
|
|
US6727280B2
(en)
*
|
1997-01-07 |
2004-04-27 |
Sonus Pharmaceuticals, Inc. |
Method for treating colorectal carcinoma using a taxane/tocopherol formulation
|
|
US20030105156A1
(en)
*
|
1997-01-07 |
2003-06-05 |
Nagesh Palepu |
Method for administration of a taxane/tocopherol formulation to enhance taxane therapeutic utility
|
|
US6045815A
(en)
*
|
1997-08-15 |
2000-04-04 |
Board Of Regents, The University Of Texas System |
Parenteral pimaricin as treatment of systemic infections
|
|
US6844004B2
(en)
|
1997-08-15 |
2005-01-18 |
Board Of Regents, The University Of Texas System |
Topical formulations of natamycin/pimaricin
|
|
NZ506389A
(en)
*
|
1998-02-05 |
2003-07-25 |
Novartis Ag |
Pharmaceutical compositions containing epothilone which can be optionally lyophilised
|
|
IL131217A0
(en)
*
|
1998-03-10 |
2001-01-28 |
Napro Biotherapeutics Inc |
Novel methods and compositions for delivery of taxanes
|
|
KR19990075621A
(ko)
*
|
1998-03-23 |
1999-10-15 |
임성주 |
경사 평판형 배양조
|
|
KR100446959B1
(ko)
*
|
1998-04-02 |
2004-11-03 |
김종국 |
파클리탁셀주사제조성물
|
|
US7030155B2
(en)
*
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
US6017948A
(en)
*
|
1998-10-30 |
2000-01-25 |
Supergen, Inc. |
Water-miscible pharmaceutical compositions
|
|
ATE289801T1
(de)
*
|
1998-12-22 |
2005-03-15 |
Us Health |
Verabreichungssystem für wasserunlösliche arzneistoffe
|
|
US6040330A
(en)
|
1999-01-08 |
2000-03-21 |
Bionumerik Pharmaceuticals, Inc. |
Pharmaceutical formulations of taxanes
|
|
US6121257A
(en)
*
|
1999-03-31 |
2000-09-19 |
Abbott Laboratories |
Sulfamate containing macrocyclic immunomodulators
|
|
EP2289549A3
(en)
|
1999-10-01 |
2011-06-15 |
Immunogen, Inc. |
Immunoconjugates for treating cancer
|
|
SE9903831D0
(sv)
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
CZ20013498A3
(cs)
*
|
2000-02-02 |
2002-04-17 |
Florida State University Research Foundation, Inc. |
Taxanové formulace mající zlepąenou rozpustnost
|
|
WO2001085216A1
(en)
|
2000-05-12 |
2001-11-15 |
Samyang Corporation |
Method for the preparation of polymeric micelle via phase separation of block copolymer
|
|
US7217770B2
(en)
*
|
2000-05-17 |
2007-05-15 |
Samyang Corporation |
Stable polymeric micelle-type drug composition and method for the preparation thereof
|
|
AU2001279168A1
(en)
*
|
2000-08-02 |
2002-02-13 |
Atossa Healthcare, Inc. |
Bimodal emulsions of taxanes and butyrate polyalcohol esters
|
|
JP2004536026A
(ja)
*
|
2000-11-28 |
2004-12-02 |
トランスフォーム ファーマシューティカルズ，インコーポレーティッド． |
パクリタキセル、その誘導体、および薬剤として許容される塩を含む医薬品製剤
|
|
EP1435908A4
(en)
*
|
2001-09-13 |
2006-03-15 |
Korea Inst Sci & Tech |
Oily paclitaxel composition and formulation for chemoembolization and preparation method thereof
|
|
AU2002357012A1
(en)
*
|
2001-11-27 |
2003-06-10 |
Transform Pharmaceuticals, Inc. |
Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
|
|
PL368945A1
(en)
*
|
2001-11-30 |
2005-04-04 |
Bristol-Myers Squibb Company |
Paclitaxel solvates
|
|
AU2002353118A1
(en)
*
|
2001-12-11 |
2003-07-24 |
Dor Biopharma, Inc. |
Lipid particles and suspensions and uses thereof
|
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
|
US20050129719A1
(en)
*
|
2003-12-15 |
2005-06-16 |
Yu-Fang Hu |
Concentrated emulsion formulation for silatecan
|
|
US20050220835A1
(en)
*
|
2004-03-30 |
2005-10-06 |
Jayaraman Ramesh B |
Agent eluting bioimplantable devices and polymer systems for their preparation
|
|
ES2410591T3
(es)
|
2004-09-22 |
2013-07-02 |
Nippon Kayaku Kabushiki Kaisha |
Nuevo copolímero en bloque, preparación micelar y agente antineoplásico que lo contiene como principio activo
|
|
WO2007014445A1
(en)
*
|
2005-08-02 |
2007-02-08 |
Miv Therapeutics Inc. |
Microdevices comprising nanocapsules for controlled delivery of drugs and method of manufacturing same
|
|
US8323669B2
(en)
*
|
2006-03-28 |
2012-12-04 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of taxane
|
|
CA2652656A1
(en)
|
2006-05-18 |
2007-11-29 |
Nippon Kayaku Kabushiki Kaisha |
High-molecular weight conjugate of podophyllotoxins
|
|
US20090239782A1
(en)
*
|
2006-10-03 |
2009-09-24 |
Masaharu Nakamura |
High-molecular weight conjugate of resorcinol derivatives
|
|
WO2008056596A1
(fr)
|
2006-11-06 |
2008-05-15 |
Nippon Kayaku Kabushiki Kaisha |
Dérivé polymère d'un antagoniste métabolique d'acide nucléique
|
|
EP2090607B1
(en)
|
2006-11-08 |
2015-05-20 |
Nippon Kayaku Kabushiki Kaisha |
Polymeric derivative of nucleic acid metabolic antagonist
|
|
EP2206502B1
(en)
|
2007-09-28 |
2018-09-12 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of steroid
|
|
AR063111A1
(es)
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
|
EP2258397B1
(en)
*
|
2008-03-18 |
2017-10-11 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of physiologically active substance
|
|
EP2284209B1
(en)
|
2008-05-08 |
2016-08-31 |
Nippon Kayaku Kabushiki Kaisha |
Polymer conjugate of folic acid or folic acid derivative
|
|
CN102421827B
(zh)
|
2009-05-15 |
2014-07-30 |
日本化药株式会社 |
具有羟基的生理活性物质的高分子结合体
|
|
CN102038636B
(zh)
*
|
2009-10-23 |
2014-08-13 |
天士力控股集团有限公司 |
一种含有螯合剂的紫杉烷类药物溶液及其制备方法
|
|
CN102038634B
(zh)
*
|
2009-10-23 |
2014-12-10 |
天士力控股集团有限公司 |
一种含有助溶剂的紫杉烷类药物溶液及其制备方法
|
|
CN102038635A
(zh)
*
|
2009-10-23 |
2011-05-04 |
天津天士力集团有限公司 |
一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法
|
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前－乳劑調配物及其製造與使用之方法
|
|
BR112012028037A2
(pt)
|
2010-05-03 |
2016-08-02 |
Teikoku Pharma Usa Inc |
formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit
|
|
TWI472340B
(zh)
*
|
2010-11-10 |
2015-02-11 |
Tasly Holding Group Co Ltd |
Taxanes containing solution and a preparation method of the co-solvent
|
|
TW201304805A
(zh)
|
2010-11-17 |
2013-02-01 |
Nippon Kayaku Kk |
新穎之胞核苷系代謝拮抗劑之高分子衍生物
|
|
WO2013035641A1
(ja)
*
|
2011-09-11 |
2013-03-14 |
日本化薬株式会社 |
ブロック共重合体の製造方法
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
CN109464382B
(zh)
*
|
2019-01-08 |
2020-10-09 |
四川大学 |
一种可注射的高载药量的紫杉醇凝胶及其制备方法和应用
|
|
JP2024537910A
(ja)
*
|
2021-10-21 |
2024-10-16 |
カシーヴ バイオサイエンシズ，リミテッド・ライアビリティ・カンパニー |
安定した希釈準備済みカルフィルゾミブ組成物
|